Grufity logo
Grufity logo
NVOS

NVOS - Novo Integrated Sciences, Inc. Stock Price, Fair Value and News

00
Delayed as of 20 Oct 2026, 04:00 pm ET

NVOS Stock Valuation Analysis

Valuation

Login to View

Max Portfolio %

Login to View

NVOS Price Action

Trailing 12 Months

-100%

NVOS RSI Chart

NVOS Stock Valuation Analysis

Valuation

Login to View

Max Portfolio %

Login to View

NVOS Valuation

Market Cap

0

Price/Earnings (Trailing)

0

Price/Sales (Trailing)

0

EV/EBITDA

0.05

Price/Free Cashflow

0

NVOS Price/Sales (Trailing)

The Good, Bad and Ugly

Growth

Profitability

Size

Dilution Risk

Balance Sheet

Momentum

Funds Popularity

Insider Trading

NVOS Fundamentals

NVOS Revenue

NVOS Earnings

NVOS Profitability

Free Cashflow Yield

0%

NVOS Investor Care

Revenue & Growth

How Novo Integrated Sciences, Inc. generates revenue and covers its expenses, based on the latest reported earnings.

Historical Charts for Stock Metrics

Get all data in R, Python etc through our Historical Stock Data APIs(opens in new tab)
Net sales
YearQ1Q2Q3Q4
202413.7M13.5M13.3M-
202312.2M12.4M12.6M13.0M
202211.1M22.6M11.7M11.9M
20217.1M8.5M9.3M10.3M
20209.9M8.4M7.9M7.5M
20199.0M9.2M9.4M9.7M
20188.7M8.9M8.9M9.0M
20177.6M7.8M8.0M8.4M
2016--7.2M7.4M
Get all data in R, Python etc through our Historical Stock Data APIs(opens in new tab)

About Novo Integrated Sciences, Inc.

NVOS
Novo Integrated Sciences, Inc., together with its subsidiaries, provides multidisciplinary primary health care related products and services. It operates through two segments, Healthcare Services and Product Sales. The company offers physiotherapy, chiropractic care, manual/manipulative therapy, occupational therapy, eldercare, massage therapy, acupuncture and functional dry needling, chiropody, stroke and traumatic brain injury/neurological rehabilitation, kinesiology, vestibular therapy, concussion management and baseline testing, trauma sensitive yoga and meditation for concussion-acquired brain injury and occupational stress-PTSD, women's pelvic health program, sports medicine therapy, assistive devices, dietitian, holistic nutrition, fall prevention education, sports team conditioning program, and private personal training services. It also engages in the assessment, diagnosis, treatment, pain management, rehabilitation, education, and prevention of various orthopedic, musculoskeletal, sports injury, and neurological conditions across various demographics, including pediatric, adult, and geriatric populations. In addition, the company offers eldercare physiotherapy services, such as long-term care homes, retirement homes, community-based home care physiotherapy, community-based group exercise classes and fall prevention programs, and community-based outpatient clinics; and elderly occupational therapy services for retirement home and community, and long-term care sectors. Further, it offers medical technology services, such as telemedicine and remote patient monitoring; and develops and distributes personalized health and wellness product solutions. The company operates corporate-owned clinics. The company is based in Bellevue, Washington. Novo Integrated Sciences, Inc. is a subsidiary of ALMC-ASAP Holdings, Inc.
 CEO
 WEBSITEnovointegrated.com
 SECTORHealthcare
 INDUSTRYMedical Care Facilities
 EMPLOYEES115

Novo Integrated Sciences, Inc. Frequently Asked Questions

NVOS is the stock ticker symbol of Novo Integrated Sciences, Inc.. Every public company that trades on a stock exchange gets a ticker symbol.

As of Fri Oct 16 2026, market cap of Novo Integrated Sciences, Inc. is 0. The market capitalization is calculated by multiplying the stock price with the number of shares outstanding.

As of Fri Oct 16 2026, NVOS's PE ratio (Price to Earnings) is 0 and Price to Sales (PS) ratio is 0. The price to earnings and price to sales ratio are two most important valuation metrics for any company. PE ratio tell us the number of years of earnings investors are ready to pay for owning the company. Historically, S&P500 price to earnings ratio has fallen below 12 during periods of gloom and gone past 30 during periods of euphoria. NVOS PE ratio will change depending on the future growth rate expectations of investors.

In the past 10 years, Novo Integrated Sciences, Inc. has provided -1 (multiply by 100 for percentage) rate of return.